Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Kiora Pharmaceuticals (KPRX) FCF Margin (2016 - 2024)

Kiora Pharmaceuticals' FCF Margin history spans 8 years, with the latest figure at 85.16% for Q1 2024.

  • For Q1 2024, FCF Margin changed N/A year-over-year to 85.16%; the TTM value through Dec 2024 reached 53.78%, changed N/A, while the annual FY2024 figure was 53.46%, N/A changed from the prior year.
  • FCF Margin reached 85.16% in Q1 2024 per KPRX's latest filing, down from 70659.92% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 383115.16% in Q1 2021 to a low of 14175.86% in Q4 2020.
  • Average FCF Margin over 3 years is 116675.78%, with a median of 70659.92% recorded in 2021.
  • The largest YoY upside for FCF Margin was 8483578bps in 2021 against a maximum downside of 8483578bps in 2021.
  • A 3-year view of FCF Margin shows it stood at 14175.86% in 2020, then soared by 598bps to 70659.92% in 2021, then crashed by -100bps to 85.16% in 2024.
  • Per Business Quant, the three most recent readings for KPRX's FCF Margin are 85.16% (Q1 2024), 70659.92% (Q4 2021), and 143694.54% (Q2 2021).